These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2414843)

  • 1. PF 4 versus beta TG as evidence for platelet activation in myeloproliferative disorders.
    Luzzatto G; Fabris F; Mazzucato M; Girolami A
    Scand J Haematol; 1985 Sep; 35(3):299-304. PubMed ID: 2414843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does the beta TG/PF4 ratio have any value in myeloproliferative diseases?
    Viero P; Cortelazzo S; Barbui T
    Thromb Haemost; 1984 Jul; 51(3):411. PubMed ID: 6208631
    [No Abstract]   [Full Text] [Related]  

  • 3. The value of beta TG/PF4 ratio in patients with high platelet count.
    Fabris F; Luzzatto G; Girolami A
    Thromb Haemost; 1985 Apr; 53(2):288-9. PubMed ID: 2410998
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma concentrations of platelet-specific proteins and serum thromboxane B2 production in response to treatment with dipyridamole. A pilot study of 27 post-myocardial infarction patients.
    Safai-Kutti S; Kutti J; Vedin A; Wilhelmsson C
    Eur Heart J; 1985 Jun; 6(6):468-72. PubMed ID: 2412820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-specific proteins in patients with transient ischemic attacks. (Effects of anti-platelet drugs).
    Fabris F; Randi ML; Crociani ME; Manzoni S; Tonin P; De Zanche L; Cella G; Girolami A
    Ric Clin Lab; 1983; 13(4):437-42. PubMed ID: 6197742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases.
    Viero P; Cortelazzo S; Bassan R; Barbui T
    Thromb Haemost; 1982 Oct; 48(2):125-6. PubMed ID: 6184841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of antiplatelet drugs on beta tg and PF4 levels in patients with transient ischemic attacks.
    Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Manzoni S; Tonin P; De Zanche L; Girolami A
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():263-5. PubMed ID: 2408445
    [No Abstract]   [Full Text] [Related]  

  • 8. Warning: platelet factor 4, beta-thromboglobulin and thromboxane in donor's plasma units.
    Stratta P; Canavese C; Peiretti F; Vallauri P; Vercellone A
    Thromb Haemost; 1983 Feb; 49(1):61. PubMed ID: 6189235
    [No Abstract]   [Full Text] [Related]  

  • 9. The clinical significance of beta-thromboglobulin and platelet factor-4 in polycythaemic patients.
    Najean Y; Poirier O; Lokiec F
    Scand J Haematol; 1983 Oct; 31(4):298-304. PubMed ID: 6194555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of two anti-platelet drugs (indobufen and dipyridamole) to improve thrombocytopenia in liver cirrhosis.
    Luzzatto G; Fabris F; Gerunda GE; Zangrandi F; Girolami A
    Acta Haematol; 1987; 77(2):101-6. PubMed ID: 2955629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of beta-thromboglobulin in patients with high platelet count.
    Fabris F; Randi ML; Casonato A; Dal Bo Zanon R; Bonvicini P; Girolami A
    Acta Haematol; 1984; 71(1):32-8. PubMed ID: 6197855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of beta-thromboglobulin and platelet factor 4 in relation to the venous platelet concentration.
    Kutti J; Safai-Kutti S; Zaroulis CG; Good RA
    Acta Haematol; 1980; 64(1):1-5. PubMed ID: 6158243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prostacyclin during cardiopulmonary bypass in men on plasma levels of beta-thromboglobulin, platelet factor 4, thromboxane B2, 6-keto-prostaglandin F1 alpha and heparin.
    Ditter H; Heinrich D; Matthias FR; Sellmann-Richter R; Wagner WL; Hehrlein FW
    Thromb Res; 1983 Nov; 32(4):393-408. PubMed ID: 6197766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
    Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
    Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activation in myeloproliferative disorders.
    Cortelazzo S; Viero P; Barbui T
    Thromb Haemost; 1981 Jun; 45(3):211-3. PubMed ID: 6169172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-thromboglobulin (author's transl)].
    Endo Y
    Rinsho Byori; 1981 Jan; 29(1):20-5. PubMed ID: 6169853
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-thromboglobulin and platelet factor 4 in polycythemia patients treated by ticlopidine.
    Najean Y; Poirier O
    Acta Haematol; 1984; 72(2):83-9. PubMed ID: 6208739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma thromboglobulin and platelet aggregation index in transient ischaemic attack: effect of aspirin and dipyridamole therapy.
    Aushri Z; Berginer V; Nathan I; Dvilansky A
    Int J Clin Pharmacol Res; 1983; 3(5):339-42. PubMed ID: 6206005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo platelet release in myeloproliferative disorders.
    Ireland H; Lane DA; Wolff S; Foadi M
    Thromb Haemost; 1982 Aug; 48(1):41-5. PubMed ID: 6215739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) in obstetrical cases.
    Arocha-Piñango CL; Ojeda A; López G; García L; Linares J
    Acta Obstet Gynecol Scand; 1985; 64(2):115-20. PubMed ID: 2580418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.